Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Moodys
Merck
Boehringer Ingelheim
Johnson and Johnson

Last Updated: August 11, 2022

Investigational Drug Information for Cellobiose


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Cellobiose?

Cellobiose is an investigational drug.

There have been 5 clinical trials for Cellobiose. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2012.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are GlaxoSmithKline, Federico II University, and [disabled in preview].

There are five hundred and twenty-seven US patents protecting this investigational drug and twenty-five international patents.

Recent Clinical Trials for Cellobiose
TitleSponsorPhase
A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in PediFederico II UniversityPhase 4
A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 DaysGlaxoSmithKlinePhase 2
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.GlaxoSmithKlinePhase 2

See all Cellobiose clinical trials

Clinical Trial Summary for Cellobiose

Top disease conditions for Cellobiose
Top clinical trial sponsors for Cellobiose

See all Cellobiose clinical trials

US Patents for Cellobiose

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cellobiose See Plans and Pricing Polypeptides having beta-xylosidase activity and polynucleotides encoding same Novozymes, Inc. (Davis, CA) See Plans and Pricing
Cellobiose See Plans and Pricing Inhalable pharmaceutical compositions iCeutica Pty Ltd. (Iluka, WA, AU) See Plans and Pricing
Cellobiose See Plans and Pricing Polymeric nanoparticles and methods of making and using same Merck Sharp & Dohme Corp. (Rahway, NJ) Pfizer Inc. (New York, NY) See Plans and Pricing
Cellobiose See Plans and Pricing Aerosol pirfenidone and pyridone analog compounds and uses thereof AVALYN PHARMA INC. (Seattle, CA) See Plans and Pricing
Cellobiose See Plans and Pricing Human anti-IL-23 antibodies, compositions, methods and uses Janssen Biotech, Inc. (Horsham, PA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cellobiose

Drugname Country Document Number Estimated Expiration Related US Patent
Cellobiose European Patent Office EP2875139 2032-07-23 See Plans and Pricing
Cellobiose United Kingdom GB201213032 2032-07-23 See Plans and Pricing
Cellobiose United Kingdom GB2505638 2032-07-23 See Plans and Pricing
Cellobiose World Intellectual Property Organization (WIPO) WO2014016576 2032-07-23 See Plans and Pricing
Cellobiose Brazil BR112016011608 2033-11-22 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Moodys
Merck
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.